Gastrointestinal Cancer News

Regular vigorous physical activity reduced the risk for hepatocellular carcinoma by approximately 45%, according to recently published data.

Near-infrared fluorescent lymphography after injection of indocyanine green enabled surgeons to effectively identify and thoroughly retrieve draining lymph nodes in patients with gastric cancer, according to a prospective, single-arm study published in JAMA Surgery.

Systemic lupus erythematosus is associated with an increased risk for 16 cancers, including Hodgkin’s and non-Hodgkin’s lymphoma, leukemia and multiple myeloma, but a decreased risk for prostate cancer and cutaneous melanoma, according to data published in Arthritis Research & Therapy.

Inhibiting platelets with clopidogrel, either alone or in combination with low-dose aspirin, helped reduce risk for colorectal cancer, according to research published in Clinical Gastroenterology and Hepatology.

Use of placebo in cancer trials of targeted and immunotherapy drugs was associated with a significant occurrence of grade 3 or grade 4 adverse events, according to results of a meta-analysis published in JAMA Network Open.

HIV-infected Hispanic adults in the United States demonstrated a higher risk for HPV-related cancers than Hispanics who did not have HIV, according to a study published in Cancer.

Researchers at UC San Diego Health have identified distinct genetic mutations in appendix cancer that could lead to new targeted treatment approaches, according to study findings published in JCO Precision Oncology.

The NIH awarded a 5-year, $693,000 grant to The Feinstein Institute for Medical Research to develop and test a digital health platform to help young female cancer survivors evaluate their options for having children and plan for the future.

Older adults had a 69% higher risk for myocardial infarction and ischemic stroke in the year prior to cancer diagnosis, according to research published in Blood.

Individuals with colorectal cancer who followed healthy diets before and after diagnosis demonstrated a reduced risk for death from the disease or any cause, according to results of a study published in Journal of Clinical Oncology.